Surgical myocardial revascularization versus stents
نویسندگان
چکیده
OBJECTIVES: To compare coronary artery bypass to stenting in our institution, and to compare the studied samples for major adverse cardiac and cerebrovascular outcomes. METHOD: An observational cohort study. We analyzed 202 patients undergoing coronary artery surgical revascularization versus stenting in our institution between January 17 and July 31, 2009; patients were stratified into: Group G1-STENT, patients who received stents; and Group G2-CABG, patients submitted to coronary artery by-pass grafting. A script containing 62 clinical, hemodynamic and surgical items was used for data collection from medical records. RESULTS:Womenmade up a higher percentage of G1-STENT 44% versus 26% in G2-CABG. Diabetics predominated in G2-CABG, 46% versus 29% in G1-STENT. Three or more coronary branches showed a higher percentage in G2CABG, 55% vs, 9.0%; in G1-STENT, 64% had only one coronary branch involvement. Non-elective procedures were higher for G1-STENT (21%vs. 9%).Worse postoperative renal function occurred inG2-CABG (15%vs. 2%). G1-STENT patients had shorter hospital time. Recurrence of angina was higher in patients in G1-STENT (11% vs. 2%) with no significant difference in hospital mortality. Postoperative quality of life increased from 45% to 55% in G2-CABG. CONCLUSIONS: Surgical revascularization is the best procedure for patients with multi vessel coronary disease, especially in diabetic patients: it allows a significantly more complete revascularization, reduces the number of readmissions due to cardiac causes, reduces the recurrence of angina and improves quality of life after surgery, with hospital and late mortality rates similar to those obtained through stenting.
منابع مشابه
Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up.
BACKGROUND Several observational reports have documented both increased and decreased cardiac mortality or Q-wave myocardial infarction with drug-eluting stents compared with bare-metal stents. METHODS We sought to evaluate the safety and efficacy of drug-eluting stents compared with bare-metal stents early after intervention (<1 year) and late (>1 year) among a broad population of patients, ...
متن کاملEverolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials
Background. Individual randomized trials have suggested that everolimus-eluting stents may have improved clinical outcomes compared to paclitaxel-eluting stents, but individual trials are underpowered to examine outcomes such as mortality and very late stent thrombosis. Methods. Medline, Cochrane, and conference proceedings were searched for randomized trials comparing everolimus versus paclita...
متن کاملDifferential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.
BACKGROUND Some (but not all) prior trials have reported differential outcomes after percutaneous coronary intervention with paclitaxel-eluting stents versus stents eluting rapamycin analogs according to the presence of diabetes mellitus. These studies lacked sufficient power to examine individual safety and efficacy end points. METHODS AND RESULTS To determine whether an interaction exists b...
متن کاملUnprotected left main intervention: the light at the end of the tunnel?
Despite impressive advances in stent technology, unprotected left main coronary artery (LMCA) disease requiring revascularization remains the province of the surgeon at most institutions. In a 2007 editorial, we summarized the evolution of percutaneous coronary intervention (PCI) for LMCA disease, concluding that given the available evidence at that time, coronary artery bypass graft surgery (C...
متن کاملUnprotected Left Main Intervention The Light at the End of the Tunnel ? Gregg
Despite impressive advances in stent technology, unprotected left main coronary artery (LMCA) disease requiring revascularization remains the province of the surgeon at most institutions. In a 2007 editorial, we summarized the evolution of percutaneous coronary intervention (PCI) for LMCA disease, concluding that given the available evidence at that time, coronary artery bypass graft surgery (C...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014